Semechkin Andrey

CIK 00014477081 companyAMHERST, NH

SEC Profile

Transactions

Companies

Filings

CIK

0001447708

Recent Transactions

50 trades

Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2023-11-06+500,000→ 500,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2022-04-25+1,000,000→ 1,000,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2021-06-09+250,000→ 250,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2019-02-28+150,000→ 150,000 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2019-01-21$1.75/sh+599,222→ 4,034,594 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2018-08-15+150,000→ 150,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2018-08-15+150,000→ 150,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2018-08-15+150,000→ 150,000 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2018-03-12+200,000→ 200,000 total
Exercise/Conversion
International Stem Cell CORP$ISCO
Stock Options (Right to Buy)
2018-02-20−15,556→ 54,444 total
Exercise/Conversion
International Stem Cell CORP$ISCO
Common Stock
2018-02-20$1.10/sh+15,556→ 3,435,372 total
Exercise/Conversion
International Stem Cell CORP$ISCO
Stock Options (Right to Buy)
2018-02-20−30,556→ 69,444 total
Exercise/Conversion
International Stem Cell CORP$ISCO
Common Stock
2018-02-20$1.09/sh+30,556→ 3,419,816 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-12-07$1.75/sh+1,860,810→ 3,389,260 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2017-05-31−70,000→ 70,000 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-05-22$1.64/sh+3,200→ 1,528,450 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-03-22$1.69/sh+3,000→ 1,525,250 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-03-21$1.60/sh+500→ 1,522,250 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-03-20$1.66/sh+6,500→ 1,521,750 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-03-14$1.59/sh+2,100→ 1,515,250 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-03-13$1.50/sh+1,000→ 1,513,150 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2017-03-10$1.32/sh+5,000→ 1,512,150 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2017-02-10−100,000→ 100,000 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Series C Warrant (Right to Buy)
2016-12-08−285,714→ 0 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2016-12-08$1.75/sh+285,714→ 1,507,150 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2016-09-14$1.75/sh+200,000→ 1,221,436 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Series B Warrant (Right to Buy)
2016-09-14−200,000→ 0 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2016-08-22$1.75/sh+154,285→ 1,021,436 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Series B Warrant (Right to Buy)
2016-08-22−154,285→ 0 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Series B Warrant (Right to Buy)
2016-06-29−215,000→ 0 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2016-06-29$1.75/sh+215,000→ 867,151 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2016-05-17+200,000→ 200,000 total
Purchase
International Stem Cell CORP$ISCO
Series A Warrant (Right to Buy)
2016-03-15−2,462,856→ 2,462,856 total
Purchase
International Stem Cell CORP$ISCO
Series C Warrant (Right to Buy)
2016-03-15−2,462,856→ 2,462,856 total
Purchase
International Stem Cell CORP$ISCO
Series B Warrant (Right to Buy)
2016-03-15−2,462,856→ 2,462,856 total
Purchase
International Stem Cell CORP$ISCO
Series I-2 Preferred Stock
2016-03-15$1000.00/sh−4,310→ 4,310 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Series A Warrant (Right to Buy)
2015-11-24−39,294→ 0 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Common Stock
2015-11-24$1.79/sh+39,294→ 652,151 total
Conversion
International Stem Cell CORP$ISCO
Series H-2 Preferred Stock
2015-11-23−380→ 0 total
Conversion
International Stem Cell CORP$ISCO
Common Stock
2015-11-23$1.79/sh+211,900→ 612,857 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2015-03-31$0.04/sh+5,894,214→ 60,143,521 total
Conversion
International Stem Cell CORP$ISCO
Series C Warrant (Right to Buy)
2015-03-31−5,894,214→ 0 total
Exercise of In-Money
International Stem Cell CORP$ISCO
Series B Warrant (Right to Buy)
2014-12-22−5,894,214→ 0 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2014-12-22$0.06/sh+5,894,214→ 54,249,307 total
Award
International Stem Cell CORP$ISCO
Stock Option (Right to Buy)
2014-11-10+60,000→ 60,000 total
Purchase
International Stem Cell CORP$ISCO
Series A Warrant (Right to Buy)
2014-10-14+5,894,214→ 5,894,214 total
Purchase
International Stem Cell CORP$ISCO
Series C Warrant (Right to Buy)
2014-10-14+5,894,214→ 5,894,214 total
Purchase
International Stem Cell CORP$ISCO
Series H-2 Preferred Stock
2014-10-14$1000.00/sh+380→ 380 total
Purchase
International Stem Cell CORP$ISCO
Series B Warrant (Right to Buy)
2014-10-14+5,894,214→ 5,894,214 total
Purchase
International Stem Cell CORP$ISCO
Common Stock
2014-09-10$0.09/sh+3,888,889→ 48,355,093 total

Companies

International Stem Cell CORP
Director, Chief Executive Officer, 10% Owner
$ISCO

Recent Filings

Address

1 OVERLOOK DRIVE, UNIT 11

AMHERST, NH, 03031

View on SEC.gov